Top Alzheimer’s Scientist Joins NeuroCog Trials

Jul 18, 2018 | Alzheimer, Investigator Content, Welsh-Bohmer, Kathleen Anne MD Content

BioIT reports that Dr. Kathleen Anne Welsh-Bohmer, a specialist in Alzheimer’s Disease (AD) research, has joined the scientific leadership team at NeuroCog Trials (NCT) as the Vice President of Neurodegenerative Disorders. In her new role she will lead the development of new technology and tools to support customers conducting clinical trials for dementia and other cognitive disorders.

View article here

Source: Bio ITWorld

0 Comments

Pin It on Pinterest